hexamethylpropyleneamine oxime

Known as: HMPAO, HMPAO oxime

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2004

The cerebral blood flow agent, 99mTc-HMPAO (‘CeretecTM’) has been investigated to see if it can be used to estimate tumour blood…

1999

Background and Purpose—To increase the reliability of 99mTc–hexamethyl propyleneamine oxime (HMPAO) single photon emission…

1998

Abstract. The relationship between impairment of consciousness and quantitative cerebral blood flow (CBF) was investigated. The…

1995

Highly Cited

1994

Highly Cited

1994

METHODS A normal atlas for HMPAO rCBF SPECT images was obtained from images of 53 normal controls. Following image registration…

1993

Gilles de la Tourette's syndrome is a complex neuropsychiatric disorder. Its onset is characteristically during childhood and it…

1993

Scintigraphy with Tc-99m labeled antigranulocyte antibodies (BW 250/183 MoABs) was performed in 32 patients with suspected…

1993

Tc-99m HMPAO, a lipophilic radiopharmaceutical used for brain imaging, has been reported to localize in smokers' lungs. To…

1990

1988